To assess the clinical relevance of each of the cholesterol biosynthesis enzymes identified within our transcriptomic and proteomic analysis, we used publicly available datasets for ER+ BC patients treated with neoadjuvant anastrozole [33] or letrozole [34]. Here, ESR1 is linked to breast cancer.